Measurement of Bone Mineral Density in HIV-Infected Individuals Who Are Not Considered as a Specific Risk Group for Bone Mineral Densitometry Screening

Abstract

Objective: As HIV-infected individuals continue to live longer with antiretroviral therapy (ART), systemic metabolic complications are also becoming more frequent. HIV-infected patients who have ART have a 2-6% reduction in bone mineral density (BMD) over the first two years. This reduction in BMD is thought to be due to the complex relationship between the virus itself, ART and the usual risk factors of osteoporosis. We aimed to investigate the possibility that the decrease in BMD occurred at younger ages in HIV-infected individuals, and to show the factors that affect it.